You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康希諾生物-B(6185.HK)漲4.48% 全國新冠疫苗接種超10億劑次
格隆匯6月21日丨康希諾生物-B(6185.HK)漲4.48%,報373元;康希諾(688185.SH)亦漲約2%。據國家衞健委消息,截至2021年6月19日,31個省(自治區、直轄市)和新疆生產建設兵團累計報吿接種新冠病毒疫苗101048.9萬劑次。3月24日,我國啟動新冠疫苗接種“日報制”。從1億劑次到2億劑次,用了25天;從2億劑次到3億劑次,用了16天。5月以來,新冠疫苗接種進入“加速跑”,從9億劑次到10億劑次僅用5天,日均接種量超過2000萬劑次。新冠疫苗概念股其它個股則漲跌不一,復星醫藥(02196.HK)跌0.82%,復星醫藥(600196.SH)漲0.13%,國藥股份(600511.SH)漲1.2%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account